Investors interested in Medical - Dental Supplies stocks are likely familiar with Becton Dickinson (BDX) and Merit Medical (MMSI) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank is a proven strategy that targets ...

产品创新 - BDX公司在过去几个月推出了一系列产品，为未来几个季度的增长奠定了良好基础[1] - BDX公司最近发布了新的细胞分选器BD FACSDiscover S8 Cell Sorters，展示了其在产品创新方面的积极态度[7] 战略合作 - BDX公司与Camtech Health和Techcyte等公司达成战略合作协议，推动了宫颈癌筛查和识别技术的进步[5][6]

FRANKLIN LAKES, N.J., April 9, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will receive the Business Group on Health "Best Employers: Excellence in Health & Well-being Award" for its commitment to advancing employee well-being through comprehensive and innovative benefits and initiatives. Best Employers: Excellence in Health and Well-being Award Logo BD also garnered honors for "Excellence in Global Health & We ...

Becton, Dickinson and Company (BDX) , popularly known as BD, recently announced the global commercial release of new cell sorters, the new BD FACSDiscover S8 Cell Sorters. This will likely enable researchers in a broader range of fields (including cell biology, cancer research and immunology) to provide insights that were previously invisible in traditional flow cytometry experiments.The new BD FACSDiscover S8 Cell Sorters feature BD CellView Image Technology and BD SpectralFX Technology. This, according to ...

New BD FACSDiscover™ S8 Cell Sorters to Enable More Researchers to Push the Boundaries of DiscoveryFRANKLIN LAKES, N.J., April 5, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of new cell sorters that will enable more researchers in a broader range of fields, including cell biology, cancer research and immunology, to reveal insights that were previously invisible in traditional flow cytometry ex ...

公司业绩 - BD将于2024年5月2日公布2024财年第二季度财务业绩[1] - BD将在东部时间上午8点举行音频网络研讨会，讨论财务业绩并更新运营和战略[2] 公司概况 - BD是一家全球领先的医疗技术公司，致力于改善医学发现、诊断和护理交付，支持医疗保健一线工作者[3]

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium also includes the Zacks Style Scores.What are the Zacks Style Scores?Develope ...

投资机会 - 投资者可以通过购买处于52周低点的股票，获得一些顶级股票的绝佳机会[1] Brown-Forman公司品牌 - Brown-Forman公司拥有一些市场上最受欢迎的饮料酒类品牌，如Jack Daniels、Woodford Reserve和Old Forester[5] Brown-Forman公司财报 - Brown-Forman公司在Q3'24报告中虽然YOY净销售额下降了1%，但其营业收入增长了116%，每股摊薄收益也增长了189%[7]

Investors interested in stocks from the Medical - Dental Supplies sector have probably already heard of Becton Dickinson (BDX) and Merit Medical (MMSI) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates a ...

FRANKLIN LAKES, N.J., March 21, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the March 19, 2024 U.S. Food and Drug Administration (FDA) Safety Communication, which provided important updates on FDA's ongoing evaluation of certain plastic syringes: Eric Borin, president of BD Medication Delivery Solutions said, "BD has the capacity to support additional syringe demand and is further increasing ...